| Identification | Back Directory | [Name]
MK-8876 | [CAS]
1426960-33-9 | [Synonyms]
MK-8876
MK 8876,MK8876
2-(4-Fluorophenyl)-5-(11-fluoro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indol-2-yl)-N-methyl-6-[methyl(methylsulfonyl)amino]-3-benzofurancarboxamide
3-Benzofurancarboxamide, 2-(4-fluorophenyl)-5-(11-fluoro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indol-2-yl)-N-methyl-6-[methyl(methylsulfonyl)amino]- | [Molecular Formula]
C32H24F2N4O5S | [MDL Number]
MFCD32204664 | [MOL File]
1426960-33-9.mol | [Molecular Weight]
614.62 |
| Hazard Information | Back Directory | [Uses]
MK-8876 is an inhibitor of HCV NS5b site D, which can be used in the research of hepatitis C virus [1][2]. | [References]
[1] McLaughlin M, Dermenjian R K, Jin Y, et al. Evaluation and control of mutagenic impurities in a development compound: purge factor estimates vs measured amounts[J]. Organic Process Research & Development, 2015, 19(11): 1531-1535.
[2] Williams M J, et al. Process Development of the HCV NS5B Site D Inhibitor MK-8876[J]. Organic Process Research & Development, 2016, 20(7): 1227-1238. |
|
|